Last reviewed · How we verify
Atom Therapeutics Co., Ltd — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
3 Phase 2
2 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Oncology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Allakos Inc. · 1 shared drug class
- Allergan · 1 shared drug class
- Amgen · 1 shared drug class
- AstraZeneca · 1 shared drug class
- BioNTech SE · 1 shared drug class
- Coherus Oncology, Inc. · 1 shared drug class
- DualityBio Inc. · 1 shared drug class
- Air Force Military Medical University, China · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Atom Therapeutics Co., Ltd:
- Atom Therapeutics Co., Ltd pipeline updates — RSS
- Atom Therapeutics Co., Ltd pipeline updates — Atom
- Atom Therapeutics Co., Ltd pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Atom Therapeutics Co., Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/atom-therapeutics-co-ltd. Accessed 2026-06-10.